Lifeboat Foundation

Leading transhumanists from a variety of backgrounds and perspectives provide concise, powerful statements as to why they are transhuman. The Transhuman Era has arrived; some of us are aware of this already, whereas others are transhuman but do not know it yet. The #IAmTranshuman campaign helps illustrate how emerging technologies and the accompanying shifts in thinking are already transforming everyday life.

This video was compiled and formatted by Tom Ross, the U.S. Transhumanist Party / Transhuman Party’s Director of Media Production: http://tomross.com/

Continue reading “#IAmTranshuman — Compilation #1 — U.S. Transhumanist Party / Transhuman Party” »

https://www.youtube.com/watch

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

SAN FRANCISCO (AP) — Ernest Quintana’s family knew he was dying of chronic lung disease when he was taken by ambulance to a hospital, unable to breathe.

But they were devastated when a robot machine rolled into his room in the intensive care unit that night and a doctor told the 78-year-old patient by video call he would likely die within days.

“If you’re coming to tell us normal news, that’s fine, but if you’re coming to tell us there’s no lung left and we want to put you on a morphine drip until you die, it should be done by a human being and not a machine,” his daughter Catherine Quintana said Friday.

In its most recent weekly US influenza surveillance report, the Centers for Disease Control and Prevention revealed that flu activity remains high across the nation. According to the agency, both the influenza A viruses H1N1 and H3N2, as well as influenza B viruses, are still making rounds through the population, with H3 viruses more frequently reported than H1N1.

The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer.

Continue Reading Below

Swiss drugmaker Roche’s Tecentriq was OK’d Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It’s to be given with chemotherapy, the standard treatment.

Continue reading “FDA approves 1st immunotherapy drug to treat breast cancer” »

As a passionate supporter of the advancement of women and recognition for their immense contributions to our world, I was thrilled to learn of a fascinating new initiative that launched today, in honor of International Women’s Day and Women’s History Month. This unique AI-powered web experience called https://www.nobelprize.org/womenwhochangedscience/” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: https://www.nobelprize.org/womenwhochangedscience/”>Women Who Changed Science highlights the achievements of female Nobel Prize winners who broke new ground in physics, chemistry and medicine. Raising awareness of their tremendous impact, the initiative aims to empower the next generation of scientists.

Women Who Changed Science is an outgrowth of a new collaboration with Nobel Media and Microsoft and is one of Microsoft’s ongoing initiatives to build female inclusion and diversity in STEM fields. This new endeavor trains a lens on the inspiring journeys and contributions of female Nobel Prize winners who’ve significantly impacted our world for the better.

Never be limited by other people’s limited imaginations… If you adopt their attitudes, then the possibility won’t exist because you’ll have already shut it out… You can hear other people’s wisdom, but you’ve got to re-evaluate the world for yourself.

As a physician, Peace Corps volunteer, entrepreneur, teacher, dancer, and astronaut, Jemison has certainly lived her life in protest of people’s limited imaginations. Born in 1956, Jemison’s interest in STEM rooted early, and she enrolled at Stanford University when she was only 16. She majored in degrees in both chemical engineering and Afro-American studies, and she went on to receive an M.D. just four years later.

Jemison worked as a medical practitioner and served for two-and-a-half years in the Peace Corps as a medical officer. When she returned to the United States in 1985, she did something incredibly difficult: She pivoted her career entirely to pursue her childhood dream of becoming an astronaut. Jemison applied to the NASA astronaut training program, was selected from a field of 2,000 individuals, and in 1992, became the first African-American woman to go to space.

A new compound discovered by scientists at Scripps Research may prove to be a powerful weapon in the fight against one of the most aggressive and deadly types of cancer. Just like the cancer it fights, the compound is incredibly strong, selectively targeting the cells that allow glioblastoma multiforme (GBM) to rapidly take over the brain.

The research, which was published in a new paper in Proceedings of the National Academy of Sciences, explains how the stem-like cancer cells of GBM promote growth of the tumor while also aiding it in recurrence even after a patient has had surgery. Stopping these cells from doing their deadly deed is crucial to successful treatment, and the new compound — which the scientists have nicknamed RIPGBM — does just that.

Researchers have developed nanobots that can be injected using an ordinary hypodermic syringe, according to a new release. The nanobots are microscopic functioning robots with the ability to walk and withstand harsh environments. Each robot has a 70-micron length, which is about the width of a thin human hair, and a million can be produced from a single 4-inch silicon composite wafer.